Meet #MiniMedChampion Jason

Jason Ziobrowski, also known as Chef Jay Z, is on a mission to influence others positively through food. Diagnosed with type 1 diabetes in his early forties, his journey has been one of transformation and resilience, as he now works as a corporate R&D chef for a leading national food and nutrition services company dedicated to serving 900+ hospitals and healthcare systems.
 

Transitioning to the MiniMed 780G system

While Jason was initially skeptical about using an insulin pump, his perspective changed after meeting another person living with type 1 diabetes who was using the MiniMed 780G pump herself. “Meeting her, and her convincing me what to do and how easy it was, really encouraged me to say, ‘All right, let’s do this,’” says Jason, who transitioned to the MiniMed 780G system in 2024.

The system has significantly improved his life by helping stabilize glucose levels.^† experiences less extreme fluctuations in blood sugar levels that he did before using the pump. “I believe the insulin pump, and the support system I have in place, have [made my life better],” he says.
 

Promoting healthy eating

Jason has a passion for educating people about healthy eating and is on a personal mission to change the American palate, one mouth at a time. Today, he develops recipes for hospital cafes and patients, conducts training sessions, and creates educational content to promote better dietary habits. His inspiring story of lowering his A1C levels and maintaining his health for over a decade through food as medicine is a testament to the power diet can play when it comes to managing chronic conditions. His efforts to educate people about the impact of diet on health and his dedication to creating nutritious meals for hospital settings are helping make a positive difference in the lives of many.

Footnote
† Refers to SmartGuard™ feature. Individual results may vary.

MiniMed^™ 780G system with SmartGuard^™ technology with Guardian^™ 4 Sensor

The MiniMed^™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed^™ 780G System includes SmartGuard^™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. 

The Medtronic MiniMed^™ 780G System consists of the following devices: MiniMed^™ 780G Insulin Pump, the Guardian^™ 4 Transmitter, the Guardian^™ 4 Sensor, One-press serter, the Accu-Chek^™ Guide Link blood glucose meter, and the Accu-Chek^™ Guide Test Strips. The system requires a prescription from a healthcare professional.

The Guardian^™ 4 Sensor is intended for use with the MiniMed^™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian^™ (4) sensor is indicated for up to seven days of continuous use. 

The Guardian^™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed^™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian^™ 4 sensor. The Guardian^™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian^™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the MiniMed^™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed^™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard^™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed^™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.